252 related articles for article (PubMed ID: 20880929)
1. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients.
Noordzij M; Cranenburg EM; Engelsman LF; Hermans MM; Boeschoten EW; Brandenburg VM; Bos WJ; Kooman JP; Dekker FW; Ketteler M; Schurgers LJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2011 May; 26(5):1662-9. PubMed ID: 20880929
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with mortality in patients new to haemodialysis.
Spiegel DM; Raggi P; Smits G; Block GA
Nephrol Dial Transplant; 2007 Dec; 22(12):3568-72. PubMed ID: 17617651
[TBL] [Abstract][Full Text] [Related]
3. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
[TBL] [Abstract][Full Text] [Related]
4. Association between aortic calcification and total and cardiovascular mortality in older women.
Rodondi N; Taylor BC; Bauer DC; Lui LY; Vogt MT; Fink HA; Browner WS; Cummings SR; Ensrud KE
J Intern Med; 2007 Mar; 261(3):238-44. PubMed ID: 17305646
[TBL] [Abstract][Full Text] [Related]
5. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
6. How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis?
Bellasi A; Kooienga L; Block GA; Veledar E; Spiegel DM; Raggi P
J Nephrol; 2009; 22(2):255-62. PubMed ID: 19384844
[TBL] [Abstract][Full Text] [Related]
7. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
8. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients.
Noordzij M; Voormolen NM; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2009 May; 24(5):1580-7. PubMed ID: 19155531
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of vertebral fractures and aortic calcifications in hemodialysis patients: comparison with a population of the same age and sex].
Rodríguez García M; Gómez Alonso C; Naves Díaz M; Díaz López JB; Megido J; Gago E; Forascepi R; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():106-11. PubMed ID: 12778865
[TBL] [Abstract][Full Text] [Related]
10. Determinants of progressive vascular calcification in haemodialysis patients.
Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
[TBL] [Abstract][Full Text] [Related]
11. [A study of aortic calcification uremia].
Nakagawa K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):135-43. PubMed ID: 9134830
[TBL] [Abstract][Full Text] [Related]
12. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
Sigrist MK; Taal MW; Bungay P; McIntyre CW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
[TBL] [Abstract][Full Text] [Related]
13. Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients.
Floege J; Raggi P; Block GA; Torres PU; Csiky B; Naso A; Nossuli K; Moustafa M; Goodman WG; Lopez N; Downey G; Dehmel B; Chertow GM;
Nephrol Dial Transplant; 2010 Jun; 25(6):1916-23. PubMed ID: 20110249
[TBL] [Abstract][Full Text] [Related]
14. Are peritoneal calcifications in long-term peritoneal dialysis related to aortic calcifications and disturbances in mineral metabolism?
Vlijm A; Phoa SS; Noordzij M; Spijkerboer AM; van Schuppen J; Stoker J; Struijk DG; Krediet RT
Nephrol Dial Transplant; 2011 Jan; 26(1):304-8. PubMed ID: 20591814
[TBL] [Abstract][Full Text] [Related]
15. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients.
Noordzij M; Boeschoten EW; Bos WJ; Dekker FW; Bossuyt PM; Krediet RT; Korevaar JC;
Nephrol Dial Transplant; 2007 Oct; 22(10):2944-9. PubMed ID: 17597087
[TBL] [Abstract][Full Text] [Related]
16. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
[TBL] [Abstract][Full Text] [Related]
17. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
[TBL] [Abstract][Full Text] [Related]
18. Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients.
Komatsu M; Okazaki M; Tsuchiya K; Kawaguchi H; Nitta K
Kidney Blood Press Res; 2014; 39(6):658-67. PubMed ID: 25571879
[TBL] [Abstract][Full Text] [Related]
19. Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers.
Wang AY; Lam CW; Chan IH; Wang M; Lui SF; Sanderson JE
Nephrol Dial Transplant; 2009 Dec; 24(12):3826-33. PubMed ID: 19574337
[TBL] [Abstract][Full Text] [Related]
20. Association of conjunctival and corneal calcification with vascular calcification in dialysis patients.
Seyahi N; Altiparmak MR; Kahveci A; Yetik H; Kanberoglu K; Serdengecti K; Ataman R; Erek E
Am J Kidney Dis; 2005 Mar; 45(3):550-6. PubMed ID: 15754277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
